Reducing the clinical burden of ranibizumab treatment for neovascular age-related macular degeneration using an individually planned regimen.
Phase of Trial: Phase IV
Latest Information Update: 18 Dec 2015
At a glance
- Drugs Ranibizumab (Primary)
- Indications Wet age-related macular degeneration
- Focus Therapeutic Use
- 18 Dec 2015 New trial record